[Obesity, metabolic syndrome and diabetes: cardiovascular implications and therapy]

Eduardo Alegría Ezquerra1, José M Castellano Vázquez, Ana Alegría Barrero

  • 1Departamento de Cardiología, Clínica Universitaria de Navarra, Pamplona, Navarra, España.

Insights

Obesity, metabolic syndrome, and type-2 diabetes mellitus are rising health concerns. Lifestyle changes and medication are crucial for preventing associated cardiovascular complications.

Area of Science:

  • Endocrinology and Metabolism
  • Cardiovascular Disease Research

Background:

  • Obesity, metabolic syndrome, and type-2 diabetes mellitus are interconnected conditions.
  • These metabolic disorders share pathophysiological pathways leading to cardiovascular complications.

Purpose of the Study:

  • To highlight the urgent need for healthcare professionals to implement preventive measures against cardiovascular complications.
  • To emphasize the importance of lifestyle modifications and pharmacological interventions.

Main Methods:

  • Review of current understanding of shared pathophysiological mechanisms.
  • Analysis of effective strategies for preventing cardiovascular complications.

Main Results:

  • Alarming increase in the prevalence of obesity, metabolic syndrome, and type-2 diabetes mellitus.
  • Lifestyle modifications are highly effective but underutilized preventive measures.

Conclusions:

  • Urgent implementation of preventive strategies is necessary for healthcare professionals.
  • A combination of lifestyle changes and targeted drug treatments is required to manage risk factors and prevent complications.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...